Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Depreciation and Depletion: 2019-2021

Historic Depreciation and Depletion for Neurocrine Biosciences (NBIX) over the last 3 years, with Dec 2021 value amounting to $3.0 million.

  • Neurocrine Biosciences' Depreciation and Depletion rose 36.36% to $3.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $10.9 million, marking a year-over-year increase of 26.74%. This contributed to the annual value of $23.5 million for FY2024, which is 32.02% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Depreciation and Depletion of $3.0 million as of Q4 2021, which was up 7.14% from $2.8 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Depreciation and Depletion ranged from a high of $3.0 million in Q4 2021 and a low of $1.6 million during Q1 2019.
  • Moreover, its 3-year median value for Depreciation and Depletion was $2.1 million (2020), whereas its average is $2.2 million.
  • Data for Neurocrine Biosciences' Depreciation and Depletion shows a peak YoY spiked of 36.36% (in 2021) over the last 5 years.
  • Neurocrine Biosciences' Depreciation and Depletion (Quarterly) stood at $2.0 million in 2019, then grew by 10.00% to $2.2 million in 2020, then surged by 36.36% to $3.0 million in 2021.
  • Its Depreciation and Depletion was $3.0 million in Q4 2021, compared to $2.8 million in Q3 2021 and $2.6 million in Q2 2021.